Drug Master Files for: dapagliflozin
✉ Email this page to a colleague
dapagliflozin Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
27838 | A | II | 6/27/2015 | ALP PHARM BEIJING CO LTD | DAPAGLIFLOZIN PROPANEDIOL |
28086 | A | II | 3/25/2014 | MSN LABORATORIES PRIVATE LTD | DAPAGLIFLOZIN PROPANEDIOL [ROUTE CODE - DQ] |
30299 | A | II | 2/29/2016 | MSN LABORATORIES PRIVATE LTD | DAPAGLIFLOZIN (AMORPHOUS) [ROUTE CODE DQa] |
30555 | A | II | 5/12/2016 | ZAKLADY FARMACEUTYCZNE POLPHARMA SA | DAPAGLIFLOZIN |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information